| The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute C Schramm, MS Spitzer, S Henke-Fahle, G Steinmetz, K Januschowski, ... Investigative ophthalmology & visual science 53 (2), 613-621, 2012 | 120 | 2012 |
| Comparative toxicity and proliferation testing of aflibercept, bevacizumab and ranibizumab on different ocular cells S Schnichels, U Hagemann, K Januschowski, J Hofmann, ... British Journal of Ophthalmology 97 (7), 917-923, 2013 | 84 | 2013 |
| Long-term results after artificial iris implantation in patients with aniridia A Rickmann, P Szurman, K Januschowski, M Waizel, MS Spitzer, ... Graefe's Archive for Clinical and Experimental Ophthalmology 254, 1419-1424, 2016 | 59 | 2016 |
| Rate and timing of spontaneous resolution in a vitreomacular traction group: should the role of watchful waiting be re-evaluated as an alternative to ocriplasmin therapy? S Dimopoulos, KU Bartz-Schmidt, F Gelisken, K Januschowski, ... British Journal of Ophthalmology 99 (3), 350-353, 2015 | 58 | 2015 |
| Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina M Lüke, K Januschowski, J Beutel, C Lüke, S Grisanti, S Peters, ... Graefe's Archive for Clinical and Experimental Ophthalmology 246, 817-822, 2008 | 58 | 2008 |
| Retinal toxicity of medical devices used during vitreoretinal surgery: a critical overview K Januschowski, C Irigoyen, JC Pastor, GK Srivastava, MR Romano, ... Ophthalmologica 240 (4), 236-243, 2018 | 51 | 2018 |
| Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment S Schnichels, N Schneider, C Hohenadl, J Hurst, A Schatz, ... PLoS One 12 (3), e0172895, 2017 | 51 | 2017 |
| The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator M Lüke, K Januschowski, M Warga, J Beutel, M Leitritz, F Gelisken, ... British journal of ophthalmology 91 (8), 1077-1082, 2007 | 48 | 2007 |
| Novel liquid bubble dissection technique for DMEK lenticule preparation P Szurman, K Januschowski, A Rickmann, LJ Damm, KT Boden, N Opitz Graefe's Archive for Clinical and Experimental Ophthalmology 254, 1819-1823, 2016 | 45 | 2016 |
| Measuring wearing times of glasses and ocular patches using a thermosensor device from orthodontics K Januschowski, TE Bechtold, TC Schott, MS Huelber‐Januschowski, ... Acta ophthalmologica 91 (8), e635-e640, 2013 | 42 | 2013 |
| Micro-invasive 360-degree suture trabeculotomy after successful canaloplasty–one year results AM Seuthe, K Januschowski, P Szurman Graefe's Archive for Clinical and Experimental Ophthalmology 254, 155-159, 2016 | 41 | 2016 |
| Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute K Januschowski, S Schnichels, J Hurst, C Hohenadl, C Reither, ... PLoS One 14 (1), e0209217, 2019 | 39 | 2019 |
| Investigation of a novel implantable suprachoroidal pressure transducer for telemetric intraocular pressure monitoring S Mariacher, M Ebner, K Januschowski, J Hurst, S Schnichels, P Szurman Experimental eye research 151, 54-60, 2016 | 37 | 2016 |
| Mycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-up D Doycheva, H Jägle, M Zierhut, C Deuter, G Blumenstock, U Schiefer, ... British Journal of Ophthalmology 99 (1), 87-91, 2015 | 37 | 2015 |
| Alginate-and hyaluronic acid–based hydrogels as vitreous substitutes: an in vitro evaluation A Schulz, A Rickmann, S Wahl, A Germann, BV Stanzel, K Januschowski, ... Translational Vision Science & Technology 9 (13), 34-34, 2020 | 34 | 2020 |
| Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results D Doycheva, M Zierhut, G Blumenstock, N Stuebiger, K Januschowski, ... British Journal of Ophthalmology 98 (4), 523-528, 2014 | 33 | 2014 |
| Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin K Januschowski, S Mueller, MS Spitzer, C Schramm, D Doycheva, ... Graefe's Archive for Clinical and Experimental Ophthalmology 250, 1013-1022, 2012 | 33 | 2012 |
| Preservative-free triamcinolone acetonide injectable suspension versus “traditional” triamcinolone preparations: impact of aggregate size on retinal biocompatibility MS Spitzer, T Mlynczak, M Schultheiss, K Rinker, E Yoeruek, ... Retina 31 (10), 2050-2057, 2011 | 33 | 2011 |
| Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty—1-year results AM Seuthe, C Ivanescu, S Leers, K Boden, K Januschowski, P Szurman Graefe's Archive for Clinical and Experimental Ophthalmology 254, 1591-1597, 2016 | 32 | 2016 |
| Toxic effects of melphalan, topotecan and carboplatin on retinal pigment epithelial cells D Süsskind, U Hagemann, M Schrader, K Januschowski, S Schnichels, ... Acta ophthalmologica 94 (5), 471-478, 2016 | 31 | 2016 |